Compare ALKT & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALKT | ATEC |
|---|---|---|
| Founded | 2007 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | 2021 | 2006 |
| Metric | ALKT | ATEC |
|---|---|---|
| Price | $16.48 | $8.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $28.57 | $22.00 |
| AVG Volume (30 Days) | 2.3M | ★ 3.3M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.04 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $152,159,000.00 | $101,739,000.00 |
| Revenue This Year | $21.85 | $18.97 |
| Revenue Next Year | $16.90 | $16.70 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 35.68 | N/A |
| 52 Week Low | $13.98 | $6.82 |
| 52 Week High | $28.53 | $23.29 |
| Indicator | ALKT | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 43.26 | 39.72 |
| Support Level | $16.10 | $8.10 |
| Resistance Level | $17.81 | $8.42 |
| Average True Range (ATR) | 0.80 | 0.41 |
| MACD | -0.13 | -0.15 |
| Stochastic Oscillator | 3.76 | 5.18 |
Alkami Technology Inc is a cloud-based digital banking solutions provider. The company offers the Alkami Digital Sales & Service Platform, which includes a digital banking platform, onboarding and account opening solutions, and data and marketing tools. The platform enables financial institutions to onboard and engage users, support revenue growth, and improve operational efficiency through a cloud-based, multi-tenant architecture. The company provides services to clients under software-as-a-service arrangements. It derives substantially all of its revenues from SaaS subscription services charged for the use of digital sales and service solutions.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.